DNAPrint Genomics, Inc. (DNAG)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 6, 2026
DNAPrint Genomics Market Cap
DNAPrint Genomics has a market cap or net worth of $1.3 thousand as of October 9, 2026. It is the 52,384th most valuable company in the world and the 8,378th biggest in the United States. Its market cap has decreased by 99.11% in one year.
Market Cap
1.30K
Enterprise Value
n/a
Revenue
1.93M
Global Rank
Country Rank
#8,378 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 1996, DNAPrint Genomics's market cap has decreased from 12.11M to 1.30K, a decrease of -99.99%. That is a compound annual growth rate of -26.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.30K | - |
| Dec 30, 2025 | 1.30K | - |
| Dec 13, 2024 | 1.30K | - |
| Dec 28, 2023 | 1.30K | - |
| Dec 30, 2022 | 1.30K | - |
| Dec 31, 2021 | 1.30K | -99.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoVista Innovative Therapies | 2.36K |
| Lipella Pharmaceuticals | 2.31K |
| Suvanza Pharma, LLC | 2.24K |
| RegeneRx Biopharmaceuticals | 1.66K |
| ZIM Corporation | 1.63K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| EV Biologics | 1.02K |